Page last updated: 2024-11-04

stallimycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3115
CHEMBL ID11252
SCHEMBL ID108585
MeSH IDM0095260

Synonyms (73)

Synonym
2n-(3,3-aminoiminopropyl)-4-[4-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-1h-2-pyrrolylcarboxamido]-1-methyl-1h-2-pyrrolecarboxamide
2n-[5-(3-amino-3-iminopropylcarbamoyl)-1-methyl-1h-3-pyrrolyl]-4-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-1h-2-pyrrolecarboxamide
cid_6602691
2n-[5-(3-amino-3-iminopropylcarbamoyl)-1-methyl-1h-3-pyrrolyl]-4-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-1h-2-pyrrolecarboxamide(distamycin a)
5n-[5-(3-amino-3-iminopropylcarbamoyl)-1-methyl-2,3-dihydro-1h-3-pyrrolyl]-3-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-2,3-dihydro-1h-5-pyrrolecarboxamide
2n-[5-(3-amino-3-iminopropylcarbamoyl)-1-methyl-1h-3-pyrrolyl]-4-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-1h-2-pyrrolecarboxamide(distamycin)
bdbm50055659
4n-[5-(3-amino-3-iminopropylcarbamoyl)-1-methyl-1h-2-pyrrolyl]-2-(4-formamido-1-methyl-1h-2-pyrrolylcarboxamido)-1-methyl-1h-4-pyrrolecarboxamide
distamycin hydrochloride
NCI60_041805
distamycin
distamycin a
stallimycin
636-47-5
NSC82150 ,
n-[5-[[5-[(3-amino-3-imino-propyl)carbamoyl]-1-methyl-pyrrol-3-yl]carbamoyl]-1-methyl-pyrrol-3-yl]-4-formamido-1-methyl-pyrrole-2-carboxamide
NSC150528 ,
n-[5-[[(amino-3-iminopropyl)amino]carbonyl]-1-methyl-1h-pyrrol-3-yl-4-[[(4-(formylamino)-1-methyl-1h-pyrrol-2yl]carbonyl]amino]-1h-pyrrole-2-carboxamide
dst-3
nsc-82150
n,4''-ter[pyrrole-2-carboxamide], n''-(2-amidinoethyl)-4-formamido-1,1',1''-trimethyl-
fi 6426
herperetin
dst-a
1h-pyrrole-2-carboxamide, n-[5-[[(3-amino-3-iminopropyl)amino]carbonyl]-1-methyl-1h-pyrrol-3-yl]-4-[[[4-(formylamino)-1-methyl-1h-pyrrol-2-yl]carbonyl]amino]-1-methyl-
NCGC00024382-03
brn 0468437
stallimycine [inn-french]
nsc 150528
nsc 82150
(n,4':n',4''-terpyrrole)-2-carboxamide, n''-(2-amidinoethyl)-4-formamido-1,1',1''-trimethyl-
distamycin 3
1h-pyrrole-2-carboxamide, n-(5-(((3-amino-3-iminopropyl)amino)carbonyl)-1-methyl-1h-pyrrol-3-yl)-4-(((4-(formylamino)-1-methyl-1h-pyrrol-2-yl)carbonyl)amino)-1-methyl-
stallimycinum [inn-latin]
estalimicina [inn-spanish]
stallimycin [inn]
stallimicina [dcit]
distamicina a [italian]
n''-(2-amidinoethyl)-4-formamido-1,1',1''-trimethyl-n-4':n'-4''-ter-(2-pyrrolcarboxamid)
NCGC00018292-01
CHEMBL11252 ,
n-[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-4-formamido-1-methylpyrrole-2-carboxamide
NCGC00018292-04
NCGC00018292-02
NCGC00018292-03
NCGC00018292-05
39389-47-4
tox21_110857
dtxsid9045637 ,
dtxcid7025637
cas-636-47-5
CCG-36393
estalimicina
distamicina a
stallimycine
stallimicina
unii-80o63p88is
80o63p88is ,
stallimycinum
n''-(2-amidinoethyl)-4-formamido-1,1',1''-trimethyl-n,4':n',4''-ter(pyrrole-2-carboxamide)
distamycin a [mi]
UPBAOYRENQEPJO-UHFFFAOYSA-N
SCHEMBL108585
sr-01000000269
SR-01000000269-3
n-(3-amino-3-iminopropyl)-4-(4-(4-formamido-1-methyl-1h-pyrrole-2-carboxamido)-1-methyl-1h-pyrrole-2-carboxamido)-1-methyl-1h-pyrrole-2-carboxamide
n-[5-({5-[(3-amino-3-iminopropyl)carbamoyl]-1-methyl-1h-pyrrol-3-yl}carbamoyl)-1-methyl-1h-pyrrol-3-yl]-4-(formylamino)-1-methyl-1h-pyrrole-2-carboxamide
distamycin; stallimycin
Q27269162
stallimycin; distamycin; herperetin; dst-a; nsc82150; unii-80o63p88is
HY-112058
CS-0043221
n-[5-[[(3-amino-3-iminopropyl)amino]carbonyl]-1-methyl-1h-pyrrol-3-yl]-4-[[[4-(formylamino)-methyl-1h-pyrrol-2-yl]carbonyl]amino]-1h-pyrrole-2-carboxamide

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Distamycin A readily inhibited nucleic acid and protein synthesis and was more toxic to the ring stage than to the trophozoite stage in various parasite strains, irrespective of their susceptibility to chloroquine."( Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands.
Ginsburg, H; Krugliak, M; Nissani, E; Williamson, DH, 1993
)
0.29

Bioavailability

ExcerptReferenceRelevance
" The bioavailability of DA in the tear fluid and the DA uptake into the cornea were increased after instillation of DA-Lipo in rabbits, reaching the DA corneal concentration corresponding to IC50 values against HSV without any sign of transcorneal permeation of drug."( Liposomes as a potential ocular delivery system of distamycin A.
Burgalassi, S; Ceccherini-Nelli, L; Chetoni, P; Matteoli, B; Monti, D; Subissi, A; Tampucci, S, 2015
)
0.42
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Furthermore, Suradista was also shown to be as effective as suramin at inhibiting the growth of sp-hst/KS3:FGF1-154-transformed NIH/3T3 xenografts grown in athymic nude mice when given at only 50% the dosage used for suramin (50 mg/kg for Suradista versus 100 mg/kg for suramin)."( Inhibition of growth factor mitogenicity and growth of tumor cell xenografts by a sulfonated distamycin A derivative.
Calabresi, P; Chen, TM; Chu, MY; Epstein, MH; Finch, PW; Friedman, S; Lipsky, MH; Maciag, T; Yee, LK, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency0.01880.000811.382244.6684AID686979
DNA polymerase kappa isoform 1Homo sapiens (human)Potency0.79430.031622.3146100.0000AID588579
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency36.12540.005612.367736.1254AID624032
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GTPase HRasHomo sapiens (human)IC50 (µMol)100.10000.00130.06820.2000AID85480; AID85481
Estrogen receptorHomo sapiens (human)IC50 (µMol)0.02000.00000.723732.7000AID68747
Neutrophil elastaseHomo sapiens (human)IC50 (µMol)100.10000.00632.073422.3780AID85480; AID85481
DNA topoisomerase 1Homo sapiens (human)IC50 (µMol)2.70000.02101.862610.0000AID211100
Histamine H1 receptorCavia porcellus (domestic guinea pig)IC50 (µMol)200.00000.00151.307210.0000AID85481
Estrogen receptor betaHomo sapiens (human)IC50 (µMol)0.02000.00010.529432.7000AID68747
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (117)

Processvia Protein(s)Taxonomy
regulation of cell cycleGTPase HRasHomo sapiens (human)
MAPK cascadeGTPase HRasHomo sapiens (human)
positive regulation of protein phosphorylationGTPase HRasHomo sapiens (human)
regulation of transcription by RNA polymerase IIGTPase HRasHomo sapiens (human)
endocytosisGTPase HRasHomo sapiens (human)
chemotaxisGTPase HRasHomo sapiens (human)
signal transductionGTPase HRasHomo sapiens (human)
cell surface receptor signaling pathwayGTPase HRasHomo sapiens (human)
Ras protein signal transductionGTPase HRasHomo sapiens (human)
positive regulation of cell population proliferationGTPase HRasHomo sapiens (human)
negative regulation of cell population proliferationGTPase HRasHomo sapiens (human)
insulin receptor signaling pathwayGTPase HRasHomo sapiens (human)
animal organ morphogenesisGTPase HRasHomo sapiens (human)
negative regulation of gene expressionGTPase HRasHomo sapiens (human)
positive regulation of phospholipase C activityGTPase HRasHomo sapiens (human)
Schwann cell developmentGTPase HRasHomo sapiens (human)
positive regulation of cell migrationGTPase HRasHomo sapiens (human)
positive regulation of type II interferon productionGTPase HRasHomo sapiens (human)
regulation of actin cytoskeleton organizationGTPase HRasHomo sapiens (human)
negative regulation of GTPase activityGTPase HRasHomo sapiens (human)
T-helper 1 type immune responseGTPase HRasHomo sapiens (human)
regulation of cell population proliferationGTPase HRasHomo sapiens (human)
myelinationGTPase HRasHomo sapiens (human)
defense response to protozoanGTPase HRasHomo sapiens (human)
positive regulation of MAP kinase activityGTPase HRasHomo sapiens (human)
positive regulation of MAPK cascadeGTPase HRasHomo sapiens (human)
negative regulation of neuron apoptotic processGTPase HRasHomo sapiens (human)
positive regulation of GTPase activityGTPase HRasHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIGTPase HRasHomo sapiens (human)
positive regulation of JNK cascadeGTPase HRasHomo sapiens (human)
fibroblast proliferationGTPase HRasHomo sapiens (human)
positive regulation of fibroblast proliferationGTPase HRasHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityGTPase HRasHomo sapiens (human)
positive regulation of epithelial cell proliferationGTPase HRasHomo sapiens (human)
T cell receptor signaling pathwayGTPase HRasHomo sapiens (human)
neuron apoptotic processGTPase HRasHomo sapiens (human)
adipose tissue developmentGTPase HRasHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeGTPase HRasHomo sapiens (human)
cellular response to gamma radiationGTPase HRasHomo sapiens (human)
positive regulation of wound healingGTPase HRasHomo sapiens (human)
positive regulation of protein targeting to membraneGTPase HRasHomo sapiens (human)
cellular senescenceGTPase HRasHomo sapiens (human)
oncogene-induced cell senescenceGTPase HRasHomo sapiens (human)
intrinsic apoptotic signaling pathwayGTPase HRasHomo sapiens (human)
regulation of neurotransmitter receptor localization to postsynaptic specialization membraneGTPase HRasHomo sapiens (human)
positive regulation of ruffle assemblyGTPase HRasHomo sapiens (human)
positive regulation of miRNA metabolic processGTPase HRasHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
antral ovarian follicle growthEstrogen receptorHomo sapiens (human)
epithelial cell developmentEstrogen receptorHomo sapiens (human)
chromatin remodelingEstrogen receptorHomo sapiens (human)
regulation of DNA-templated transcriptionEstrogen receptorHomo sapiens (human)
signal transductionEstrogen receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayEstrogen receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationEstrogen receptorHomo sapiens (human)
androgen metabolic processEstrogen receptorHomo sapiens (human)
male gonad developmentEstrogen receptorHomo sapiens (human)
negative regulation of gene expressionEstrogen receptorHomo sapiens (human)
positive regulation of phospholipase C activityEstrogen receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayEstrogen receptorHomo sapiens (human)
intracellular estrogen receptor signaling pathwayEstrogen receptorHomo sapiens (human)
response to estradiolEstrogen receptorHomo sapiens (human)
regulation of toll-like receptor signaling pathwayEstrogen receptorHomo sapiens (human)
negative regulation of smooth muscle cell apoptotic processEstrogen receptorHomo sapiens (human)
negative regulation of canonical NF-kappaB signal transductionEstrogen receptorHomo sapiens (human)
negative regulation of DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
response to estrogenEstrogen receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionEstrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
fibroblast proliferationEstrogen receptorHomo sapiens (human)
positive regulation of fibroblast proliferationEstrogen receptorHomo sapiens (human)
stem cell differentiationEstrogen receptorHomo sapiens (human)
regulation of inflammatory responseEstrogen receptorHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
RNA polymerase II preinitiation complex assemblyEstrogen receptorHomo sapiens (human)
uterus developmentEstrogen receptorHomo sapiens (human)
vagina developmentEstrogen receptorHomo sapiens (human)
prostate epithelial cord elongationEstrogen receptorHomo sapiens (human)
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesisEstrogen receptorHomo sapiens (human)
regulation of branching involved in prostate gland morphogenesisEstrogen receptorHomo sapiens (human)
mammary gland branching involved in pregnancyEstrogen receptorHomo sapiens (human)
mammary gland alveolus developmentEstrogen receptorHomo sapiens (human)
epithelial cell proliferation involved in mammary gland duct elongationEstrogen receptorHomo sapiens (human)
protein localization to chromatinEstrogen receptorHomo sapiens (human)
cellular response to estradiol stimulusEstrogen receptorHomo sapiens (human)
negative regulation of miRNA transcriptionEstrogen receptorHomo sapiens (human)
regulation of epithelial cell apoptotic processEstrogen receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
cellular response to estrogen stimulusEstrogen receptorHomo sapiens (human)
proteolysisNeutrophil elastaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINeutrophil elastaseHomo sapiens (human)
response to yeastNeutrophil elastaseHomo sapiens (human)
leukocyte migration involved in inflammatory responseNeutrophil elastaseHomo sapiens (human)
biosynthetic process of antibacterial peptides active against Gram-negative bacteriaNeutrophil elastaseHomo sapiens (human)
proteolysisNeutrophil elastaseHomo sapiens (human)
intracellular calcium ion homeostasisNeutrophil elastaseHomo sapiens (human)
response to UVNeutrophil elastaseHomo sapiens (human)
extracellular matrix disassemblyNeutrophil elastaseHomo sapiens (human)
protein catabolic processNeutrophil elastaseHomo sapiens (human)
response to lipopolysaccharideNeutrophil elastaseHomo sapiens (human)
negative regulation of chemokine productionNeutrophil elastaseHomo sapiens (human)
negative regulation of interleukin-8 productionNeutrophil elastaseHomo sapiens (human)
positive regulation of interleukin-8 productionNeutrophil elastaseHomo sapiens (human)
defense response to bacteriumNeutrophil elastaseHomo sapiens (human)
positive regulation of MAP kinase activityNeutrophil elastaseHomo sapiens (human)
positive regulation of smooth muscle cell proliferationNeutrophil elastaseHomo sapiens (human)
negative regulation of inflammatory responseNeutrophil elastaseHomo sapiens (human)
positive regulation of immune responseNeutrophil elastaseHomo sapiens (human)
negative regulation of chemotaxisNeutrophil elastaseHomo sapiens (human)
pyroptosisNeutrophil elastaseHomo sapiens (human)
neutrophil-mediated killing of gram-negative bacteriumNeutrophil elastaseHomo sapiens (human)
neutrophil-mediated killing of fungusNeutrophil elastaseHomo sapiens (human)
positive regulation of leukocyte tethering or rollingNeutrophil elastaseHomo sapiens (human)
phagocytosisNeutrophil elastaseHomo sapiens (human)
acute inflammatory response to antigenic stimulusNeutrophil elastaseHomo sapiens (human)
DNA topological changeDNA topoisomerase 1Homo sapiens (human)
chromatin remodelingDNA topoisomerase 1Homo sapiens (human)
circadian rhythmDNA topoisomerase 1Homo sapiens (human)
response to xenobiotic stimulusDNA topoisomerase 1Homo sapiens (human)
programmed cell deathDNA topoisomerase 1Homo sapiens (human)
phosphorylationDNA topoisomerase 1Homo sapiens (human)
peptidyl-serine phosphorylationDNA topoisomerase 1Homo sapiens (human)
circadian regulation of gene expressionDNA topoisomerase 1Homo sapiens (human)
embryonic cleavageDNA topoisomerase 1Homo sapiens (human)
chromosome segregationDNA topoisomerase 1Homo sapiens (human)
DNA replicationDNA topoisomerase 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
signal transductionEstrogen receptor betaHomo sapiens (human)
cell-cell signalingEstrogen receptor betaHomo sapiens (human)
negative regulation of cell growthEstrogen receptor betaHomo sapiens (human)
intracellular estrogen receptor signaling pathwayEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityEstrogen receptor betaHomo sapiens (human)
cellular response to estradiol stimulusEstrogen receptor betaHomo sapiens (human)
regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
cellular response to estrogen stimulusEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (50)

Processvia Protein(s)Taxonomy
GTPase activityGTPase HRasHomo sapiens (human)
G protein activityGTPase HRasHomo sapiens (human)
protein bindingGTPase HRasHomo sapiens (human)
GTP bindingGTPase HRasHomo sapiens (human)
GDP bindingGTPase HRasHomo sapiens (human)
protein-membrane adaptor activityGTPase HRasHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEstrogen receptorHomo sapiens (human)
TFIIB-class transcription factor bindingEstrogen receptorHomo sapiens (human)
transcription coregulator bindingEstrogen receptorHomo sapiens (human)
transcription corepressor bindingEstrogen receptorHomo sapiens (human)
transcription coactivator bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificEstrogen receptorHomo sapiens (human)
chromatin bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
nuclear receptor activityEstrogen receptorHomo sapiens (human)
steroid bindingEstrogen receptorHomo sapiens (human)
protein bindingEstrogen receptorHomo sapiens (human)
calmodulin bindingEstrogen receptorHomo sapiens (human)
beta-catenin bindingEstrogen receptorHomo sapiens (human)
zinc ion bindingEstrogen receptorHomo sapiens (human)
TBP-class protein bindingEstrogen receptorHomo sapiens (human)
enzyme bindingEstrogen receptorHomo sapiens (human)
protein kinase bindingEstrogen receptorHomo sapiens (human)
nitric-oxide synthase regulator activityEstrogen receptorHomo sapiens (human)
nuclear estrogen receptor activityEstrogen receptorHomo sapiens (human)
nuclear estrogen receptor bindingEstrogen receptorHomo sapiens (human)
estrogen response element bindingEstrogen receptorHomo sapiens (human)
identical protein bindingEstrogen receptorHomo sapiens (human)
ATPase bindingEstrogen receptorHomo sapiens (human)
14-3-3 protein bindingEstrogen receptorHomo sapiens (human)
sequence-specific double-stranded DNA bindingEstrogen receptorHomo sapiens (human)
protease bindingNeutrophil elastaseHomo sapiens (human)
transcription corepressor activityNeutrophil elastaseHomo sapiens (human)
endopeptidase activityNeutrophil elastaseHomo sapiens (human)
serine-type endopeptidase activityNeutrophil elastaseHomo sapiens (human)
protein bindingNeutrophil elastaseHomo sapiens (human)
heparin bindingNeutrophil elastaseHomo sapiens (human)
peptidase activityNeutrophil elastaseHomo sapiens (human)
cytokine bindingNeutrophil elastaseHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA bindingDNA topoisomerase 1Homo sapiens (human)
chromatin bindingDNA topoisomerase 1Homo sapiens (human)
double-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
single-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
RNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA topoisomerase type I (single strand cut, ATP-independent) activityDNA topoisomerase 1Homo sapiens (human)
protein serine/threonine kinase activityDNA topoisomerase 1Homo sapiens (human)
protein bindingDNA topoisomerase 1Homo sapiens (human)
ATP bindingDNA topoisomerase 1Homo sapiens (human)
DNA binding, bendingDNA topoisomerase 1Homo sapiens (human)
protein domain specific bindingDNA topoisomerase 1Homo sapiens (human)
supercoiled DNA bindingDNA topoisomerase 1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEstrogen receptor betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEstrogen receptor betaHomo sapiens (human)
DNA bindingEstrogen receptor betaHomo sapiens (human)
nuclear steroid receptor activityEstrogen receptor betaHomo sapiens (human)
nuclear receptor activityEstrogen receptor betaHomo sapiens (human)
steroid bindingEstrogen receptor betaHomo sapiens (human)
protein bindingEstrogen receptor betaHomo sapiens (human)
zinc ion bindingEstrogen receptor betaHomo sapiens (human)
enzyme bindingEstrogen receptor betaHomo sapiens (human)
nuclear estrogen receptor activityEstrogen receptor betaHomo sapiens (human)
estrogen response element bindingEstrogen receptor betaHomo sapiens (human)
receptor antagonist activityEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (35)

Processvia Protein(s)Taxonomy
glutamatergic synapseGTPase HRasHomo sapiens (human)
Golgi membraneGTPase HRasHomo sapiens (human)
nucleoplasmGTPase HRasHomo sapiens (human)
cytoplasmGTPase HRasHomo sapiens (human)
endoplasmic reticulum membraneGTPase HRasHomo sapiens (human)
Golgi apparatusGTPase HRasHomo sapiens (human)
cytosolGTPase HRasHomo sapiens (human)
plasma membraneGTPase HRasHomo sapiens (human)
perinuclear region of cytoplasmGTPase HRasHomo sapiens (human)
GTPase complexGTPase HRasHomo sapiens (human)
plasma membraneGTPase HRasHomo sapiens (human)
nucleusEstrogen receptorHomo sapiens (human)
nucleoplasmEstrogen receptorHomo sapiens (human)
transcription regulator complexEstrogen receptorHomo sapiens (human)
cytoplasmEstrogen receptorHomo sapiens (human)
Golgi apparatusEstrogen receptorHomo sapiens (human)
cytosolEstrogen receptorHomo sapiens (human)
plasma membraneEstrogen receptorHomo sapiens (human)
membraneEstrogen receptorHomo sapiens (human)
chromatinEstrogen receptorHomo sapiens (human)
euchromatinEstrogen receptorHomo sapiens (human)
protein-containing complexEstrogen receptorHomo sapiens (human)
nucleusEstrogen receptorHomo sapiens (human)
extracellular regionNeutrophil elastaseHomo sapiens (human)
extracellular spaceNeutrophil elastaseHomo sapiens (human)
cytoplasmNeutrophil elastaseHomo sapiens (human)
cytosolNeutrophil elastaseHomo sapiens (human)
cell surfaceNeutrophil elastaseHomo sapiens (human)
secretory granuleNeutrophil elastaseHomo sapiens (human)
azurophil granule lumenNeutrophil elastaseHomo sapiens (human)
specific granule lumenNeutrophil elastaseHomo sapiens (human)
phagocytic vesicleNeutrophil elastaseHomo sapiens (human)
collagen-containing extracellular matrixNeutrophil elastaseHomo sapiens (human)
extracellular exosomeNeutrophil elastaseHomo sapiens (human)
transcription repressor complexNeutrophil elastaseHomo sapiens (human)
extracellular spaceNeutrophil elastaseHomo sapiens (human)
nuclear chromosomeDNA topoisomerase 1Homo sapiens (human)
P-bodyDNA topoisomerase 1Homo sapiens (human)
fibrillar centerDNA topoisomerase 1Homo sapiens (human)
male germ cell nucleusDNA topoisomerase 1Homo sapiens (human)
nucleusDNA topoisomerase 1Homo sapiens (human)
nucleoplasmDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
perikaryonDNA topoisomerase 1Homo sapiens (human)
protein-DNA complexDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
nucleoplasmEstrogen receptor betaHomo sapiens (human)
mitochondrionEstrogen receptor betaHomo sapiens (human)
intracellular membrane-bounded organelleEstrogen receptor betaHomo sapiens (human)
chromatinEstrogen receptor betaHomo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (132)

Assay IDTitleYearJournalArticle
AID208559Apparent binding constant to T4 coliphage DNA was evaluated by measuring the loss of ethidium fluorescence1993Journal of medicinal chemistry, Apr-02, Volume: 36, Issue:7
In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycin.
AID425456Binding affinity to DNA minor groove region CGCAAATTTGCG assessed as melting temperature at 6 uM by thermal denaturation study2009Bioorganic & medicinal chemistry letters, Jul-15, Volume: 19, Issue:14
Synthesis and evaluation of a netropsin-proximicin-hybrid library for DNA binding and cytotoxicity.
AID336011Displacement of ethidium bromide from calf thymus type 1 DNA after 24 hrs by microtiter assay1992Journal of natural products, Nov, Volume: 55, Issue:11
A colorimetric microassay for the detection of agents that interact with DNA.
AID477412Antibacterial activity against Staphylococcus aureus NCTC 8325 harboring genetic deletion of mepR gene after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID54252Relative binding constant to calf thymus DNA1989Journal of medicinal chemistry, Oct, Volume: 32, Issue:10
Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation.
AID336010Displacement of methyl green from DNA after 24 hrs by microtiter assay1992Journal of natural products, Nov, Volume: 55, Issue:11
A colorimetric microassay for the detection of agents that interact with DNA.
AID101066Inhibition of growth in L1210 leukemia cells resistant to Tallimustine.2000Journal of medicinal chemistry, Jul-13, Volume: 43, Issue:14
Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
AID477418Antibacterial activity against Staphylococcus aureus NCTC 8325 carrying expression vector pG154 with mepA gene after 16 to 20 hrs by broth microdilution method in presence of anhydrous tetracycline2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID54250Apparent binding constant was determined by ethidium displacement assay in calf thymus1994Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8
In vitro photoinduced cytotoxicity and DNA binding properties of psoralen and coumarin conjugates of netropsin analogues: DNA sequence-directed alkylation and cross-link formation.
AID162405Apparent binding constant was determined by ethidium displacement assay in pol (dA-dT)1994Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8
In vitro photoinduced cytotoxicity and DNA binding properties of psoralen and coumarin conjugates of netropsin analogues: DNA sequence-directed alkylation and cross-link formation.
AID99172Median survival time of treated to the control was determined in L1210/LPAM cell line1989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.
AID99289In vivo optimal nontoxic dose against murine L1210 leukemia cells after ip treatment on day 1 after tumor ip transplant2000Journal of medicinal chemistry, Jul-13, Volume: 43, Issue:14
Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
AID477813Downregulation of ribA gene expression in MBX-1090-resistant Staphylococcus aureus isolate d20A1 at 50 ug/ml by RT-PCR analysis relative to wild type2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID477432Induction of mepA gene expression in Staphylococcus aureus NCTC 8325 at 50 ug/ml by RT-PCR analysis2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID425457Binding affinity to DNA minor groove region CGCAAATTTGCG assessed as change in melting temperature at 6 uM by thermal denaturation study2009Bioorganic & medicinal chemistry letters, Jul-15, Volume: 19, Issue:14
Synthesis and evaluation of a netropsin-proximicin-hybrid library for DNA binding and cytotoxicity.
AID1127638Antiviral activity against HPV16 assessed as inhibition of viral replication2013Bioorganic & medicinal chemistry, Oct-15, Volume: 21, Issue:20
Programmable DNA-binding small molecules.
AID1232411Selectivity index, ratio of GIC50 for mouse RAW264.7 cells to MIC for Mycobacterium tuberculosis H37Rv2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides.
AID84455Inhibitory concentration that reduced the viability of HT 29 cell population by 50%.1997Journal of medicinal chemistry, Jan-17, Volume: 40, Issue:2
Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.
AID477420Antibacterial activity against Staphylococcus aureus NCTC 8325 harboring genetic deletion of mepRA gene and carrying expression vector pG154 after 16 to 20 hrs by broth microdilution method in presence of anhydrous tetracycline2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID235114Ratio between IC50 value on resistant cells and sensitive cells2000Journal of medicinal chemistry, Jul-13, Volume: 43, Issue:14
Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
AID1232406Antimycobacterial activity against Mycobacterium bovis BCG after 7 days2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides.
AID395133Binding affinity to poly(dA).poly(dT) duplex DNA assessed as ratio of KA to KB by ESI-MS analysis2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Ligand binding to nucleic acids and proteins: Does selectivity increase with strength?
AID477410Antibacterial activity against Staphylococcus aureus NCTC 8325 after 16 to 20 hrs by broth microdilution method in presence of efflux pump inhibitor reserpine2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID425458Binding affinity to DNA minor groove region CATGGCCATG assessed as melting temperature at 6 uM by thermal denaturation study2009Bioorganic & medicinal chemistry letters, Jul-15, Volume: 19, Issue:14
Synthesis and evaluation of a netropsin-proximicin-hybrid library for DNA binding and cytotoxicity.
AID152720Inhibitory effect on the proliferation of murine leukemia (P388) cells1989Journal of medicinal chemistry, Oct, Volume: 32, Issue:10
Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation.
AID55299Concentration required to displace 50% of the ethidium from a preformed, intercalated complex2002Bioorganic & medicinal chemistry letters, Jan-21, Volume: 12, Issue:2
Polyhydroxylated azepanes as new motifs for DNA minor groove binding agents.
AID477811Modulation of protein A gene expression in MBX-1090-resistant Staphylococcus aureus isolate d20A1 at 50 ug/ml by RT-PCR analysis relative to wild type2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID477422Antibacterial activity against Staphylococcus aureus NCTC 8325 harboring genetic deletion of mepRA gene and carrying expression vector pG154 with mepA gene after 16 to 20 hrs by broth microdilution method in presence of anhydrous tetracycline2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID201237In vitro antimicrobial activity against Methicillin resistant Staphylococcus aureus2002Journal of medicinal chemistry, Feb-14, Volume: 45, Issue:4
Minor groove DNA binders as antimicrobial agents. 1. Pyrrole tetraamides are potent antibacterials against vancomycin resistant Enterococci [corrected] and methicillin resistant Staphylococcus aureus.
AID707545Induction of DNA damage in human BJ cells expressing hTERT and SV40 early region assessed as damaged foci colocalized with TRF1 at 0.1 to 0.5 uM after 24 hrs by deconvolution microscopy analysis2012Journal of medicinal chemistry, Nov-26, Volume: 55, Issue:22
Shooting for selective druglike G-quadruplex binders: evidence for telomeric DNA damage and tumor cell death.
AID54426Denaturation temperature change on binding to calf thymus DNA1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID101068Inhibition of growth in L1210 leukemia cells resistant to doxorubicin(DX).2000Journal of medicinal chemistry, Jul-13, Volume: 43, Issue:14
Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
AID220343Apparent binding constant to calf thymus DNA was evaluated by measuring the loss of ethidium fluorescence1993Journal of medicinal chemistry, Apr-02, Volume: 36, Issue:7
In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycin.
AID54424Denaturation temperature change on binding on GC to poly(dGC)-poly(dGC)1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID55500Concentration required to give 50% fluorescence quenching of bound ethidium for [ethidium]: [poly(dA-dT)]2 DNA in ratio of 0.1:1 at pH 51997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
AID477812Downregulation of ribH gene expression in MBX-1090-resistant Staphylococcus aureus isolate d20A1 at 50 ug/ml by RT-PCR analysis relative to wild type2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID225773Association constant against polynucleotide poly (dG-dC)1989Journal of medicinal chemistry, May, Volume: 32, Issue:5
Synthesis, DNA binding, and biological evaluation of synthetic precursors and novel analogues of netropsin.
AID230140Tested in vitro for the resistance index ratio (ID50) of L1210/LPAM to L1210 cell line1989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.
AID85480Tested for 50% inhibition of generation of Human Ha-ras polymerase chain reaction(PCR) products2000Journal of medicinal chemistry, Jul-13, Volume: 43, Issue:14
Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
AID55310ability to interact with DNA was assessed by a DNA/ethidium bromide dye displacement assay, expressed as DC50 for polydAdT2002Bioorganic & medicinal chemistry letters, May-06, Volume: 12, Issue:9
Induction of apoptosis by aryl-substituted diamines: role of aromatic group substituents and distance between nitrogens.
AID99170Tested in vitro for the cytotoxicity as number of viable cells against L1210/LPAM cell line after 72 hr treatment at conc. of 10E-61989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.
AID477413Antibacterial activity against Staphylococcus aureus NCTC 8325 harboring genetic deletion of mepRA gene after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID477411Antibacterial activity against MBX-1090-resistant Staphylococcus aureus isolate d20A1 after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID477423Selectivity ratio of MIC for MBX-1090-resistant Staphylococcus aureus isolate d20A1 to MIC for Staphylococcus aureus NCTC 83252010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID54423Denaturation temperature change on binding to AT to poly (dA)-poly(dT)1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID23682Partition coefficient of the compound (logP)2000Journal of medicinal chemistry, Aug-24, Volume: 43, Issue:17
DNA binding, solubility, and partitioning characteristics of extended lexitropsins.
AID477810Upregulation of conventional hypothetical protein mRNA expression in MBX-1090-resistant Staphylococcus aureus isolate d20A1 at 50 ug/ml by RT-PCR analysis relative to wild type2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID212744Inhibition of telomerase before assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID99171Tested in vivo for optimal non-toxic dose against L1210/LPAM cell line in CDF1 mice1989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.
AID477414Antibacterial activity against Staphylococcus aureus NCTC 8325 harboring genetic deletion of mepRAB gene after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID101073In vitro antitumor activity evaluated against L1210 murine leukemia cell line2000Journal of medicinal chemistry, Jul-13, Volume: 43, Issue:14
Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
AID313362Binding affinity to G.A-20 DNA duplex by CD titration2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Characterization of distamycin A binding to damaged DNA.
AID1123776Displacement of ethidium from poly[d(G-C)]-poly[d(G-C)] DNA (unknown origin) by fluorimetric method1979Journal of medicinal chemistry, Feb, Volume: 22, Issue:2
Potential antitumor agents. 29. Quantitative structure-activity relationships for the antileukemic bisquaternary ammonium heterocycles.
AID477416Antibacterial activity against Staphylococcus aureus NCTC 8325 carrying expression vector pG154 after 16 to 20 hrs by broth microdilution method in presence of anhydrous tetracycline2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID221966Toxicity assessed in human T-cells using a colorimetric cell proliferation assay.2002Journal of medicinal chemistry, Feb-14, Volume: 45, Issue:4
Minor groove DNA binders as antimicrobial agents. 1. Pyrrole tetraamides are potent antibacterials against vancomycin resistant Enterococci [corrected] and methicillin resistant Staphylococcus aureus.
AID313360Binding affinity to MG.C-20 DNA duplex by CD titration2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Characterization of distamycin A binding to damaged DNA.
AID477814Downregulation of ribE gene expression in MBX-1090-resistant Staphylococcus aureus isolate d20A1 at 50 ug/ml by RT-PCR analysis relative to wild type2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID1232412Binding affinity to 192 base-pair fragment HexB 5-TAATTA-3 (unknown origin) at 5 to 10 uM after 30 mins by DNaSeI footprinting assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides.
AID310776Antiproliferative activity against human K562 cells2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Hybrid molecules between distamycin A and active moieties of antitumor agents.
AID46169Inhibitory concentration against ethidium:Calf thymus DNA(0.1:1) binding at pH 51997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
AID313361Binding affinity to OG.A-20 DNA duplex by CD titration2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Characterization of distamycin A binding to damaged DNA.
AID28674Distribution coefficient of the compound at pH 7.4 (logD)2000Journal of medicinal chemistry, Aug-24, Volume: 43, Issue:17
DNA binding, solubility, and partitioning characteristics of extended lexitropsins.
AID162422Association constant against the polynucleotide poly (dA-dT).1989Journal of medicinal chemistry, May, Volume: 32, Issue:5
Synthesis, DNA binding, and biological evaluation of synthetic precursors and novel analogues of netropsin.
AID310778Antiproliferative activity against mouse L1210 cells2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Hybrid molecules between distamycin A and active moieties of antitumor agents.
AID46133Inhibitory concentration against ethidium:calf thymus DNA (1.26:1) binding at pH 51997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
AID54427DNA binding activity as denaturation temperatures on AT to poly (dA)-poly(dT) normalized to ethidium bromide1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID212741Inhibition of purified telomerase of Euplotes aediculatus at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID310780Antiproliferative activity against human Molt/4 cells2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Hybrid molecules between distamycin A and active moieties of antitumor agents.
AID477456Upregulation of mepR gene expression in MBX-1090-resistant Staphylococcus aureus isolate d20A1 at 50 ug/ml by RT-PCR analysis relative to wild type2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID1232407Cytotoxicity against mouse RAW264.7 cells2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides.
AID1123770Displacement of ethidium from calf thymus DNA by fluorimetric method1979Journal of medicinal chemistry, Feb, Volume: 22, Issue:2
Potential antitumor agents. 29. Quantitative structure-activity relationships for the antileukemic bisquaternary ammonium heterocycles.
AID313359Binding affinity to AP.A-20 DNA duplex by CD titration2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Characterization of distamycin A binding to damaged DNA.
AID98124Median survival time of treated to the control mice with L1210 tumor cells1989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.
AID86203Tested in vitro for the cytotoxicity as number of viable cells against Hep-2 cell line after 72 hr treatment at conc. of 10E-61989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.
AID55298Concentration required for 50% displacement of ethidium bromide from p[dA]p[dT] in a fluorescence intercalator displacement (FID) assay2002Bioorganic & medicinal chemistry letters, Sep-16, Volume: 12, Issue:18
Synthesis and DNA binding properties of saturated distamycin analogues.
AID310777Antiproliferative activity against human Jurkat cells2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Hybrid molecules between distamycin A and active moieties of antitumor agents.
AID101494In vitro effect on human leukemia K562 cell proliferation1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
Design, synthesis and biological activity of a pyrrolo [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid.
AID26756DNA binding dissociation constant as KD1984Journal of medicinal chemistry, Apr, Volume: 27, Issue:4
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
AID66271In vitro antimicrobial activity against Vancomycin resistant enterococcus strain UCD-32002Journal of medicinal chemistry, Feb-14, Volume: 45, Issue:4
Minor groove DNA binders as antimicrobial agents. 1. Pyrrole tetraamides are potent antibacterials against vancomycin resistant Enterococci [corrected] and methicillin resistant Staphylococcus aureus.
AID477815Downregulation of ribD gene expression in MBX-1090-resistant Staphylococcus aureus isolate d20A1 at 50 ug/ml by RT-PCR analysis relative to wild type2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID28758Changes in the DNA melting temperature of an AT-rich dodecamer (CGATTATTAAGC) (GCTTAATAATCG) upon binding of an equimolar amount of compound2002Journal of medicinal chemistry, Feb-14, Volume: 45, Issue:4
Minor groove DNA binders as antimicrobial agents. 1. Pyrrole tetraamides are potent antibacterials against vancomycin resistant Enterococci [corrected] and methicillin resistant Staphylococcus aureus.
AID310781Antiproliferative activity against human CEM cells2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Hybrid molecules between distamycin A and active moieties of antitumor agents.
AID68748Inhibition of human estrogen receptor(ER) polymerase-chain reaction product1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
Design, synthesis and biological activity of a pyrrolo [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid.
AID54425DNA binding property estimated by measuring denaturation temperature on GC to poly (dGC)-poly(dGC), normalized to ethidium bromide1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID477809Upregulation of mepB gene expression in MBX-1090-resistant Staphylococcus aureus isolate d20A1 at 50 ug/ml by RT-PCR analysis relative to wild type2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID66269In vitro antimicrobial activity against Vancomycin resistant enterococcus strain BM41472002Journal of medicinal chemistry, Feb-14, Volume: 45, Issue:4
Minor groove DNA binders as antimicrobial agents. 1. Pyrrole tetraamides are potent antibacterials against vancomycin resistant Enterococci [corrected] and methicillin resistant Staphylococcus aureus.
AID208549Apparent binding constant was determined by ethidium displacement assay in coliphage T4 DNA1994Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8
In vitro photoinduced cytotoxicity and DNA binding properties of psoralen and coumarin conjugates of netropsin analogues: DNA sequence-directed alkylation and cross-link formation.
AID310779Antiproliferative activity against mouse FM3A cells2007Bioorganic & medicinal chemistry, Jan-01, Volume: 15, Issue:1
Hybrid molecules between distamycin A and active moieties of antitumor agents.
AID477419Antibacterial activity against Staphylococcus aureus NCTC 8325 harboring genetic deletion of mepRA gene and carrying expression vector pG154 after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID55646The ionization constant (pKa) for the compound2000Journal of medicinal chemistry, Aug-24, Volume: 43, Issue:17
DNA binding, solubility, and partitioning characteristics of extended lexitropsins.
AID98695Inhibitory effect on the proliferation of murine leukemia (L1210 ) cells1989Journal of medicinal chemistry, Oct, Volume: 32, Issue:10
Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation.
AID477415Antibacterial activity against Staphylococcus aureus NCTC 8325 carrying expression vector pG154 after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID477421Antibacterial activity against Staphylococcus aureus NCTC 8325 harboring genetic deletion of mepRA gene and carrying expression vector pG154 with mepA gene after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID98949Tested in vivo for optimal non-toxic dose against L1210 cell line in CDF1 mice1989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.
AID211100Inhibit supercoil relaxation property of topoisomerase I.1997Journal of medicinal chemistry, Jan-17, Volume: 40, Issue:2
Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.
AID425459Binding affinity to DNA minor groove region CATGGCCATG assessed as change in melting temperature at 6 uM by thermal denaturation study2009Bioorganic & medicinal chemistry letters, Jul-15, Volume: 19, Issue:14
Synthesis and evaluation of a netropsin-proximicin-hybrid library for DNA binding and cytotoxicity.
AID72032Inhibitory effect on the proliferation of murine mammary carcinoma (FM3A ) cells1989Journal of medicinal chemistry, Oct, Volume: 32, Issue:10
Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation.
AID99286In vivo median survival time of treated vs untreated mice x 100 against murine L1210 leukemia cells after ip treatment on day 1 after tumor iv transplant2000Journal of medicinal chemistry, Jul-13, Volume: 43, Issue:14
Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
AID225774Apparent binding constant to poly (dG.dC) DNA was evaluated by measuring the loss of ethidium fluorescence1993Journal of medicinal chemistry, Apr-02, Volume: 36, Issue:7
In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycin.
AID1232413Binding affinity to 192 base-pair fragment HexB 5-CAATTG-3 (unknown origin) at 5 to 10 uM after 30 mins by DNaSeI footprinting assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides.
AID477417Antibacterial activity against Staphylococcus aureus NCTC 8325 carrying expression vector pG154 with mepA gene after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID68747Tested for 50% inhibition of generation of Human estrogen receptor polymerase chain reaction(PCR) products2000Journal of medicinal chemistry, Jul-13, Volume: 43, Issue:14
Synthesis and antitumor activity of new benzoheterocyclic derivatives of distamycin A.
AID313358Binding affinity to T.A-20 DNA duplex by CD titration2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Characterization of distamycin A binding to damaged DNA.
AID477808Upregulation of mepA gene expression in MBX-1090-resistant Staphylococcus aureus isolate d20A1 at 50 ug/ml by RT-PCR analysis relative to wild type2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID212743Inhibition of telomerase after assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID162424Ratio of association constant of poly (dA-dT) and poly (dG-dC)1989Journal of medicinal chemistry, May, Volume: 32, Issue:5
Synthesis, DNA binding, and biological evaluation of synthetic precursors and novel analogues of netropsin.
AID707546Induction of DNA damage in human BJ cells expressing hTERT and SV40 early region at 0.5 uM after 24 hrs by immunofluorescence analysis2012Journal of medicinal chemistry, Nov-26, Volume: 55, Issue:22
Shooting for selective druglike G-quadruplex binders: evidence for telomeric DNA damage and tumor cell death.
AID55499Concentration required to give 50% fluorescence quenching of bound ethidium for [ethidium]: [(poly dG-dC)]2 DNA in ratio of 0.1:1 at pH 51997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
AID1232405Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides.
AID86328Tested in vitro for the dose inhibiting cell proliferation by 50% against HeLa cell line after 24 hr treatment at conc. of 10E-61989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.
AID212902Inhibition of human telomerase after assembly using recombinant hTR and hTERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID1232408Binding affinity to 192 base-pair fragment HexB (unknown origin) at 5 to 10 uM after 30 mins by DNaSeI footprinting assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides.
AID165910Inhibitory effect on the proliferation of human B lymphoblast (Raji ) cells1989Journal of medicinal chemistry, Oct, Volume: 32, Issue:10
Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation.
AID477433Induction of mepR gene expression in Staphylococcus aureus NCTC 8325 at 50 ug/ml by RT-PCR analysis2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID95872Inhibitory concentration that reduced the viability of KB cell population by 50%.1997Journal of medicinal chemistry, Jan-17, Volume: 40, Issue:2
Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.
AID1232414Binding affinity to 192 base-pair fragment HexB 5-TTATAA-3 (unknown origin) at 5 to 10 uM after 30 mins by DNaSeI footprinting assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides.
AID162549Apparent binding constant was determined by ethidium displacement assay in poly (dG-dC)1994Journal of medicinal chemistry, Apr-15, Volume: 37, Issue:8
In vitro photoinduced cytotoxicity and DNA binding properties of psoralen and coumarin conjugates of netropsin analogues: DNA sequence-directed alkylation and cross-link formation.
AID46135Inhibitory concentration against ethidium:Calf thymus DNA (1.26:1) binding at pH 71997Journal of medicinal chemistry, Nov-07, Volume: 40, Issue:23
1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
AID212903Inhibition of human telomerase before assembly using recombinant hTR and hTERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID477409Antibacterial activity against Staphylococcus aureus NCTC 8325 after 16 to 20 hrs by broth microdilution method2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
AID200294Inhibitory concentration that reduced the viability of SKVLB cell population by 50%.1997Journal of medicinal chemistry, Jan-17, Volume: 40, Issue:2
Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.
AID96948Tested in vitro for the cytotoxicity as number of viable cells against L1210 cell line after 72 hr treatment at conc. of 10E-61989Journal of medicinal chemistry, Apr, Volume: 32, Issue:4
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives.
AID225772Apparent binding constant to poly (dA.dT) DNA was evaluated by measuring the loss of ethidium fluorescence1993Journal of medicinal chemistry, Apr-02, Volume: 36, Issue:7
In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycin.
AID85481Inhibition of Ha-ras polymerase-chain reaction product1998Bioorganic & medicinal chemistry letters, Nov-03, Volume: 8, Issue:21
Design, synthesis and biological activity of a pyrrolo [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid.
AID1123775Displacement of ethidium from poly[d(A-T)]-poly[d(A-T)] DNA by fluorimetric method1979Journal of medicinal chemistry, Feb, Volume: 22, Issue:2
Potential antitumor agents. 29. Quantitative structure-activity relationships for the antileukemic bisquaternary ammonium heterocycles.
AID1232409Binding affinity to 192 base-pair fragment HexB (unknown origin) at 1 to 10 uM after 30 mins by DNaSeI footprinting assay2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides.
AID55466Apparent binding constant was calculated2002Bioorganic & medicinal chemistry letters, Jan-21, Volume: 12, Issue:2
Polyhydroxylated azepanes as new motifs for DNA minor groove binding agents.
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (449)

TimeframeStudies, This Drug (%)All Drugs %
pre-199086 (19.15)18.7374
1990's173 (38.53)18.2507
2000's145 (32.29)29.6817
2010's40 (8.91)24.3611
2020's5 (1.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.32 (24.57)
Research Supply Index6.19 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews35 (7.22%)6.00%
Case Studies12 (2.47%)4.05%
Observational0 (0.00%)0.25%
Other438 (90.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]